Pfizer Inc. (PFE) President of R&D, Dolsten Mikael, has engaged in a transaction involving the company's stock on September 12, 2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Mikael after the transaction. The action reflects the ongoing financial activities of Pfizer's executives and may be of interest to current and potential investors.

Pfizer Inc. (PFE) President of R&D, Dolsten Mikael, has engaged in a transaction involving the company's stock on September 12, 2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The report also did not provide information on the number of shares held by Mikael after the transaction. The action reflects the ongoing financial activities of Pfizer's executives and may be of interest to current and potential investors.